Site Search

>> Advanced Search

Free Newsletter

  Email address:
   

>> Preview...
In the News

Greg Scott joined Foley's Eye on China web conference.
>> More information…

Baxter Pays $24 Million To Bring JV In-house

publication date: Jan 30, 2008
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Baxter International will take its Shanghai Baxter JV completely in-house by buying the 40% stake in the JV that had been owned by Worldbest Treeful Pharmaceutical. Worldbest is in financial trouble, and the Bank of China ordered the JV stake to be put up for auction. Worldbest Treeful originally invested $4.8 million for a 40% participation in the venture. Baxter paid 180 million RMB, about $24.3 million, to acquire the position. More details...

Stock Symbol: (NYSE: BAX) 




Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...


Login

 

 
   
  Subscribe 
Forgot password?
>> Login help...
ChinaBio® Events
Munich, Germany
November 14, 2010
Suzhou, China
November 17-18, 2010
>>More details...
 
Partner Events

BioPharm America™ 2010
Boston, MA, USA
September 15–17, 2010
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners